Dec 30 (Reuters) - Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, ...
Shares of Vanda Pharmaceuticals were trading above previous 52-week highs in the after-hours market, following news that the U.S. Food and Drug Administration approved Nereus as a treatment to prevent ...
“Totals through New Year’s Day will generally range from 0.75 to 2.50 inches across coastal and valley areas with 2.00-5.50 ...
As demand for fiber laser engraver for metal, CO2 laser cutter and engraver, and other advanced laser engraving equipment grows, small businesses and professional workshops are increasingly seeking ...
Summary • Vanda Pharmaceuticals’ shares surged 22.1% to $8.58 in after-hours trading following FDA approval of its motion ...
Eco anxiety is very real, so we share this year's most uplifting stories to prove there’s hope for our climate.
Euronews on MSN
Cheap solar power and endangered animal comebacks: Positive environmental stories from 2025
Do you share our anxiety about the state of the planet? As green journalists, we are all too familiar with what climate anxiety, climate doom, and even environmental existential dread feel like. These ...
2hon MSN
NCAA tries to clarify NBA stance after Baylor’s addition of 2023 draft pick prompts criticism
The NCAA said Tuesday it would not grant eligibility to any player who had signed an NBA contract after Baylor’s midseason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results